NEW YORK, March 9 (GenomeWeb News) - Promega and EraGen Biosciences have entered a distribution partnership that gives Promega exclusive rights to quantitative gene expression assays using technology developed by EraGen.

Promega has global distribution rights for the assays. Promega will develop and manufacture reagent systems in its Madison, Wis., facility, while EraGen will provide its patented chemistry and proprietary software for nucleic acid detection.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

New Scientist reports that 20 percent of human and yeast proteins are uncharacterized.

The University of Zurich's Ruedi Aebersold and his colleagues analyzed a dozen HeLa cell lines to find differences in gene expression, protein levels, and more.

In Nature this week: protein-coding variants associated with body-fat distribution, and more.